Cancer Drug Doesn't Speed Up Tumor Growth, Researchers Say

(HealthDay News) — The anticancer drug Sutent (sunitinib) does not cause tumors to grow faster after treatment ends, according to a new study.

Previous research in animals suggested that tumor growth may accelerate after patients stopped taking Sutent. The new findings, from a study of kidney cancer patients, indicate that the drug does not pose lingering risks for humans. read more.

2013-03-08T18:33:32+00:00